Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
5.09
+0.22 (4.52%)
At close: Oct 24, 2025, 4:00 PM EDT
4.909
-0.180 (-3.55%)
After-hours: Oct 24, 2025, 7:59 PM EDT
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $13.29 million as of October 24, 2025. Its market cap has decreased by -29.29% in one year.
Market Cap
13.29M
Enterprise Value
13.44M
1-Year Change
-29.29%
Ranking
Category
Stock Price
$5.09
Market Cap Chart
Since March 31, 2014, Ekso Bionics Holdings's market cap has decreased from $250.40M to $13.29M, a decrease of -94.69%. That is a compound annual growth rate of -22.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 12.70M | -5.22% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | -57.31% |
| Mar 31, 2014 | 250.40M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |